510(k) Report

510(k) · Cleared

Cleared

Endotine Transbleph Device

K040740510(k) TraditionalCleared May 10, 200449-day reviewClass II21 CFR 888.3040

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Coapt Systems, Inc. · HWC Screw, Fixation, Bone

Cleared on May 10, 2004 as substantially equivalent to K014153 (Coapt Systems, Inc., 2002) and 3 other predicates after a 49-day review. Its family tree reaches back 3 generations to 2002. 2 later devices descend from it.

Decided
May 10, 2004
Review
49 days
Class
Class II
Product code
HWC
Recalls
None
Predicates
4

Its longest line of descent runs back 3 generations to K014153 (2002). 4 ancestors in all, the oldest K974309 (1998). 2 later devices descend from it, 2 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 1998: 1 other ancestor2006: 1 descendant cleared2004: 1 descendant clearedK014153 · Coapt Systmes Endotine Device · Coapt Systems, Inc. · 2002K023922 · Coapt Systems Endotine Device, Model CFD-101-00197 · Coapt Systems, Inc. · 2002K033524 · Coapt Endotine Chin 3.5 Device · Coapt Systems, Inc. · 20031995200020052010201520202025
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor 1 generation forward: 2 descendants K033524 · Coapt Endotine Chin 3.5 Device · Coapt Systems, Inc. · 2003K023922 · Coapt Systems Endotine Device, Model CFD-101-00197 · Coapt Systems, Inc. · 2002K014153 · Coapt Systmes Endotine Device · Coapt Systems, Inc. · 20020
  1. Root · 3 generations backK014153 Coapt Systmes Endotine DeviceCoapt Systems, Inc. · 2002
  2. 2 generations backK023922 Coapt Systems Endotine Device, Model CFD-101-00197Coapt Systems, Inc. · 2002
  3. 1 generation backK033524 Coapt Endotine Chin 3.5 DeviceCoapt Systems, Inc. · 2003
  4. This deviceK040740 Endotine Transbleph DeviceCoapt Systems, Inc. · 2004
  5. Descendant · cites it directly · 0 of its ownK060248 Ultratine TransblephCoapt Systems, Inc. · 2006
  6. Descendant · cites it directly · 0 of its ownK042796 Endotine Transbleph 3.0/3.5 DeviceCoapt Systems, Inc. · 2004 · Recalled

Most influential descendants

Showing 2 of 2 · See all
  • K060248Ultratine TransblephCoapt Systems, Inc. · 2006 · cites it directly0descendants
  • K042796Endotine Transbleph 3.0/3.5 DeviceCoapt Systems, Inc. · 2004 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K014153Coapt Systmes Endotine DeviceCoapt Systems, Inc.2002—
−2K023922Coapt Systems Endotine Device, Model CFD-101-00197Coapt Systems, Inc.2002—
−1K033524Coapt Endotine Chin 3.5 DeviceCoapt Systems, Inc.2003—
0 (this device)K040740Endotine Transbleph DeviceCoapt Systems, Inc.2004—
+1K060248Ultratine TransblephCoapt Systems, Inc.2006—
+1K042796Endotine Transbleph 3.0/3.5 DeviceCoapt Systems, Inc.20041

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199810

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200410
200610
FIG. 1 — Lineage of K040740, 2002–2006Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in HWC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new HWC device

  1. #1 K203011 Monster Screw Systemscore 22.2 · 14 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (4)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K014153Coapt Systmes Endotine Device
Summary page 2
…510(k) or PMA Number ENDOT[NE ForeheadTM Coapt Systems, Inc. K014153/K023992 Device Lactosorb® Panels Walter Lorenz Surgical K974309 ENDOTINE Chin TM 3.5…
Coapt Systems, Inc.2002—
*K023922Coapt Systems Endotine Device, Model CFD-101-00197
Our reading of the summary gave K023992, FDA’s number for Wiener Lab Colinesterasa AA (Wiener Laboratories Saic). Corrected to the number one digit away whose FDA name carries the summary’s words for the device, “ENDOTINE Forehead Device”.
Coapt Systems, Inc.2002—
*K974309Lactosorb Panels
Summary page 2
…Number ENDOT[NE ForeheadTM Coapt Systems, Inc. K014153/K023992 Device Lactosorb® Panels Walter Lorenz Surgical K974309 ENDOTINE Chin TM 3.5 Coapt Systems, Inc. K033524 Device DEVICE DESCRIPTION The ENDOTINE TransBlep…
Biomet, Inc.1998—
*K033524Coapt Endotine Chin 3.5 Device
Summary page 2
…K014153/K023992 Device Lactosorb® Panels Walter Lorenz Surgical K974309 ENDOTINE Chin TM 3.5 Coapt Systems, Inc. K033524 Device DEVICE DESCRIPTION The ENDOTINE TransBlephTM Device kit consists of the brow implant with insertion tool and a dril…
Coapt Systems, Inc.2003—

Also cleared against K014153: 7 other devices →

What descends from it? (2)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K060248Ultratine TransblephCoapt Systems, Inc.20060
K042796Endotine Transbleph 3.0/3.5 DeviceCoapt Systems, Inc.20040

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 2 years and passes through 1 company; a new generation was cleared every 9 months on median.
  • None of the 4 ancestors has a recall.
  • Of its descendants, K060248 (Coapt Systems, Inc., 2006) has gone furthest, with 0 descendants of its own.
  • 7 other devices also cite its predicate K014153.

How does its category compare?

All HWC devices

HWC Screw, Fixation, Bone: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · HWC

15in 2025

2007: 352008: 332009: 272010: 232011: 352012: 202013: 252014: 312015: 412016: 262017: 402018: 202019: 302020: 282021: 262022: 262023: 242024: 172025: 152026 (partial year): 21
2007high 41 (2015) · low 15 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · HWC

111in 2025

2007: 77 days median2008: 76 days median2009: 113 days median2010: 110 days median2011: 88 days median2012: 99 days median2013: 90 days median2014: 88 days median2015: 85 days median2016: 131 days median2017: 127 days median2018: 106 days median2019: 108 days median2020: 75 days median2021: 84 days median2022: 167 days median2023: 104 days median2024: 90 days median2025: 111 days median2026 (partial year): 125 days median
2007high 167 (2022) · low 75 (2020)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · HWC

1in 2025

2007: 252008: 332009: 292010: 72011: 122012: 302013: 142014: 22015: 52016: 42017: 42018: 12019: 52020: 42021: 22022: 132025: 12026 (partial year): 2
2007high 33 (2008) · low 0 (2023)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · HWC

2,893in 2025

2007: 6692008: 6602009: 6512010: 7652011: 1,1042012: 3,3392013: 3,8502014: 2,5492015: 2,7112016: 2,2852017: 2,5612018: 3,6622019: 5,4632020: 4,8202021: 4,4462022: 3,9342023: 3,7182024: 3,5752025: 2,893
2007high 5,463 (2019) · low 651 (2009)2025

MAUDE reports naming product code HWC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007357725669
2008337633660
20092711329651
2010231107765
20113588121,104
20122099303,339
20132590143,850
2014318822,549
2015418552,711
20162613142,285
20174012742,561
20182010613,662
20193010855,463
2020287544,820
2021268424,446
202226167133,934
20232410403,718
2024179003,575
20251511112,893
2026211252—

What is it indicated for?

The ENDOTINE TransBlephTM Device is intended for use in subperiosteal browplasty fixation. The ENDOTINE TransBleph TM is specifically indicated for use to fixate the sub-dermis to the frontal bone.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K040740: Endotine Transbleph Device.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K040740

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026